Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A selective ALK inhibitor in ALK-rearranged patients.

× No keyword cloud information.

5 in total

Review 1. Ten things you should know about protein kinases: IUPHAR Review 14.

Authors: Doriano Fabbro; Sandra W Cowan-Jacob; Henrik Moebitz
Journal: Br J Pharmacol Date: 2015-03-24 Impact factor: 8.739

Review 2. Treating patients with ALK-positive non-small cell lung cancer: latest evidence and management strategy.

Authors: Bin-Chi Liao; Chia-Chi Lin; Jin-Yuan Shih; James Chih-Hsin Yang
Journal: Ther Adv Med Oncol Date: 2015-09 Impact factor: 8.168

3. Dramatic response to alectinib in a patient of ALK-rearranged lung cancer with poor performance status.

Authors: Hisashi Tanaka; Kageaki Taima; Takeshi Morimoto; Kunihiko Nakamura; Yoshihito Tanaka; Masamichi Itoga; Shingo Takanashi; Ken Okumura
Journal: BMC Res Notes Date: 2016-03-17

4. Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma.

Authors: Da Hyun Kang; Sung Soo Jung; Min-Kyung Yeo; Da Hye Lee; Geon Yoo; Sang Yeon Cho; In-Jae Oh; Ju-Ock Kim; Hee Sun Park; Chaeuk Chung; Jeong Eun Lee
Journal: BMC Cancer Date: 2020-06-18 Impact factor: 4.430

Review 5. Spotlight on brigatinib and its potential in the treatment of patients with metastatic ALK-positive non-small cell lung cancer who are resistant or intolerant to crizotinib.

Authors: Rohit K Jain; Hongbin Chen
Journal: Lung Cancer (Auckl) Date: 2017-10-13

5 in total